Genitope GTOP | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Genitope GTOP

An SI Board Since October 2003

Posts	SubjectMarks	Bans	Symbol
37	8	0	GTOP

Emcee: Tech Master	Type: Unmoderated

Introduction Market Data Compact

Genitope Corporation is a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. Immunotherapy products are designed to utilize the immune system to combat diseases such as cancer. Our lead product candidate, MyVax™ Personalized Immunotherapy (previously referred to as GTOP-99) is currently in a pivotal Phase 3 trial for the treatment of follicular non-Hodgkin's lymphoma (f-NHL).

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
37	Genitope Corp. will slim down to about 20 workers from nearly 200 and will seek	Paul Lee	-	3/14/2008
36	Genitope Corporation to Suspend Development of MyVax(R) Personalized Immunothera	Paul Lee	-	3/10/2008
35	Amen! chuckle.... just looked at the agenda for H&Q. Saw that Array was	scaram(o)uche	-	1/7/2008
34	Good luck (and to everyone else too) in 08.... less ughs and more highs.	kenhott	-	1/7/2008
33	glad you didn't lose bucks. I did, but only on a small "participation&	scaram(o)uche	-	12/23/2007
32	Not unexpected but too bad. I made a complex trade trying to leave the door ope	kenhott	-	12/21/2007
31	juxtaposition of the two punch lines..... no stat sig highly stat sig, pre-def	scaram(o)uche	-	12/20/2007
30	Genitope Corporation Reports Initial Results of Phase 3 Clinical Trial of MyVax(	scaram(o)uche	-	12/20/2007
29	Damn, he spends a ton of time cheerleading for shorts, even when he's balanc	scaram(o)uche	-	11/20/2007
28	Genitope Poised for Huge Swing By Adam Feuerstein Senior Writer 11/20/2007 5:5	Doc Bones	-	11/20/2007
27	Biogen Idec?? Must be a small nobody. <swap out their idiotype> It is i	kenhott	-	10/16/2007
26	>> What news re: B Lym companies?? << Biogen Idec, up for sale. Th	scaram(o)uche	-	10/16/2007
25	I am looking because for good reasons there is no expectation in any of these st	kenhott	-	10/16/2007
24	too late..... the B lymphoma companies are being picked off..... gtop shou	scaram(o)uche	-	10/12/2007
23	I've looked at them on and off, not with any real effort for many years. Th	scaram(o)uche	-	10/12/2007
22	I started looking yesterday and gave myself a headache. I am going to have trou	kenhott	-	10/11/2007
21	while this sucker may eventually be found to suffer from CTIC-like syndrome, it&	scaram(o)uche	-	10/10/2007
20	If anyone needs an anti-IDIOType therapy it is me. I plan to take a look at thi	kenhott	-	10/10/2007
19	messages.finance.yahoo.com Reported on Briefing.com at 8:14... GTOP Genitope:	scaram(o)uche	-	10/9/2007
18	9-Oct-2007 Entry into a Material Definitive Agreement Item 1.01. Entry into a	scaram(o)uche	-	10/9/2007
17	just parking a couple of links that I've lost before..... jnci.oxfordjourna	scaram(o)uche	-	10/5/2007
16	Genitope Corporation Initiates Clinical Trial to Evaluate Use of MyVax(R) Person	Paul Lee	-	5/21/2007
15	the recent conference call re. nothing. this offering... the price that shar	scaram(o)uche	-	4/26/2007
14	expected to price Thursday.... 5.5m shares, Punk Ziegel.	scaram(o)uche	-	4/24/2007
13	news yesterday of an offering, 5.5 million shares coming, or something in that n	scaram(o)uche	-	4/20/2007

Go to reply# or date (mm/dd/yy):